Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.

Item

http://www.wikidata.org/entity/Q40170291

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.

@en

type

Item

label

Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.

@en

prefLabel

Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.

@en

P1476

Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.

@en

P2093

Guangping Li

http://www.w3.org/2001/XMLSchema#string

Konstantinos P Letsas

http://www.w3.org/2001/XMLSchema#string

Panagiotis Korantzopoulos

http://www.w3.org/2001/XMLSchema#string

Qingmiao Shao

http://www.w3.org/2001/XMLSchema#string

Tong Liu

http://www.w3.org/2001/XMLSchema#string

Zhiwei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

A comparison of the aldosterone-blocking agents eplerenone and spironolactone

Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling

Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention.

Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials.

Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.

P304

672-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1093/EUROPACE/EUV366

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290212573

http://www.w3.org/2001/XMLSchema#string

P698

26705563

http://www.w3.org/2001/XMLSchema#string